Psoriatic Arthritis

Largest, most representative PsA data registry available for licensing, analytics, and collaboration

Research-Grade RWD in PsA

Unmet Need

Disease with no cure

With no cure for PsA, early diagnosis and effective treatment are the best ways to help reduce damaging effects and improve patients’ quality of life.

Deep Clinical Data

61,200+*

PsA patients followed prospectively with deep clinical, lab, and other linked data

*Counts complete through Q2 2023

Analytics & Modeling

413,000+*

PsA patients in the OM1 Real-World Data Cloud that can be used for modeling, analysis, and other research purposes

Why OM1 PsA?

Sample Use Cases

» Feasibility	» Comparative Effectiveness
» Passive Safety	» Natural History

Interested in exploring Psoriasis patients too?

Check out our Dermatology network

» Dermatology Registry

Webinar: Real-World Data for R&D for Autoimmune & Chronic Diseases

Infosheet

Learn about the OM1 PsA Registry:

Abstracts & Posters

Poster (AAD 2023): Patient-Reported Outcomes and Changes in DMARD Therapy Among Psoriatic Arthritis Patients Treated in Routine Clinical Practice

Poster (AAD 2023): Comparison of Improvements in Psoriatic Arthritis Disease Activity between Classes of Biologic Disease Modifying Anti-Rheumatic Drugs in Routine Clinical Practice: Findings from a Large Contemporaneous Real-World Cohort

Request a Meeting

Name*
First Last
Company Name*
Job Title*
Email*
Message*
Email
This field is for validation purposes and should be left unchanged.